Experimental studies have shown that hyperuricemia leads to elevated levels of agents of systemic inflammation such as interleukin 6 (IL-6), tumor necrosis factor a (TNF-a) and C-reactive protein (CRP) [43]. The gene discussed is IL6; the disease is hyperuricemia.